OMX Ventures — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Finch Therapeuticsfinchtherapeutics.comin𝕏Feb 2018
Finch is a microbiome therapeutics company that develops innovative microbiome assets designed from human microbiota transplantation studies, targeting a range of therapeutic areas.
BiotechMedical DevicesSomerville, US
R. J. Price(Director)Jeffery A. Smisek(Director)Mark Smith(Executive Officer, Director)Andrew Mulderry(Director)Chris Lange(Director)James Burgess(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.